CTFFR and Prediction of Non-Significant CAD Lesions
ConditionChronic Coronary Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-80
SponsorShiraz University of Medical Sciences
About this trial
In this prospective cohort study, 250 patients with suspected or known CAD and at least one intermediate coronary lesion (50-70% stenosis) who had a NiFFR value greater than 0.80 underwent coronary computed tomography angiography (CCTA) with NiFFR assessment. Patients were followed for one year to monitor for MACE
Eligibility criteria
Qualifiers
Patients were enrolled if they had at least one intermediate coronary lesion (classified as 50-70% diameter stenosis on visual judgment) on CCTA and then underwent FFR testing
Disqualifiers
Patients having past coronary artery bypass graft surgery (CABG)
previous PCI in the target vascular
significant renal impairment define with eGFR < 30 mL/min/1.73 m²
contrast allergy
Trial design
Treatments tested in this trial
- NIFFR
Treatment groups
250 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov